REPORT ID 4527

EMEA (Europe, Middle East and Africa) Asthma Drugs Market Report 2019

Publish Date
2019
Pages
100
Format
Electronic (PDF)

In this report, the EMEA Asthma Drugs market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Asthma Drugs for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Asthma Drugs market competition by top manufacturers/players, with Asthma Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline
    Sanofi
    Roche & Novartis
    Teva
    Merck
    AstraZeneca
    Boehringer Ingelheim
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Long-term Control Medications
    Quick-relief Medications (Rescue Medications)
    Medications for Allergy-induced Asthma

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Asthma Drugs Market  Report 2019
1 Asthma Drugs Overview
    1.1 Product Overview and Scope of Asthma Drugs
    1.2 Classification of Asthma Drugs
        1.2.1 EMEA Asthma Drugs Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Asthma Drugs Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Long-term Control Medications
        1.2.4 Quick-relief Medications (Rescue Medications)
        1.2.5 Medications for Allergy-induced Asthma
    1.3 EMEA Asthma Drugs Market by Application/End Users
        1.3.1 EMEA Asthma Drugs Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 EMEA Asthma Drugs Market by Region
        1.4.1 EMEA Asthma Drugs Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Asthma Drugs ( 2014-2024)
        1.5.1 EMEA Asthma Drugs Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Asthma Drugs Revenue and Growth Rate ( 2014-2024)

2 EMEA Asthma Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Asthma Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Asthma Drugs Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Asthma Drugs Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Asthma Drugs Sale Price by Players ( 2014-2019)
    2.2 EMEA Asthma Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Asthma Drugs Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Asthma Drugs Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Asthma Drugs Sale Price by Type ( 2014-2019)
    2.3 EMEA Asthma Drugs (Volume) by Application
    2.4 EMEA Asthma Drugs (Volume and Value) by Region
        2.4.1 EMEA Asthma Drugs Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Asthma Drugs Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Asthma Drugs Sales Price by Region ( 2014-2019)

3 Europe Asthma Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Asthma Drugs Sales and Value ( 2014-2019)
        3.1.1 Europe Asthma Drugs Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Asthma Drugs Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Asthma Drugs Sales and Market Share by Type
    3.3 Europe Asthma Drugs Sales and Market Share by Application
    3.4 Europe Asthma Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Asthma Drugs Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Asthma Drugs Revenue by Countries ( 2014-2019)
        3.4.3 Germany Asthma Drugs Sales and Growth Rate ( 2014-2019)
        3.4.4 France Asthma Drugs Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Asthma Drugs Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Asthma Drugs Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Asthma Drugs Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Asthma Drugs Sales and Growth Rate ( 2014-2019)

4 Middle East Asthma Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Asthma Drugs Sales and Value ( 2014-2019)
        4.1.1 Middle East Asthma Drugs Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Asthma Drugs Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Asthma Drugs Sales and Market Share by Type
    4.3 Middle East Asthma Drugs Sales and Market Share by Application
    4.4 Middle East Asthma Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Asthma Drugs Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Asthma Drugs Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Asthma Drugs Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Asthma Drugs Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Asthma Drugs Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Asthma Drugs Sales and Growth Rate ( 2014-2019)

5 Africa Asthma Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Asthma Drugs Sales and Value ( 2014-2019)
        5.1.1 Africa Asthma Drugs Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Asthma Drugs Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Asthma Drugs Sales and Market Share by Type
    5.3 Africa Asthma Drugs Sales and Market Share by Application
    5.4 Africa Asthma Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Asthma Drugs Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Asthma Drugs Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Asthma Drugs Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Asthma Drugs Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Asthma Drugs Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Asthma Drugs Sales and Growth Rate ( 2014-2019)

6 EMEA Asthma Drugs Manufacturers/Players Profiles and Sales Data
    6.1 GlaxoSmithKline
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Asthma Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline Asthma Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Asthma Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Asthma Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Roche & Novartis
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Asthma Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Roche & Novartis Asthma Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Teva
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Asthma Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Teva Asthma Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Merck
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Asthma Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Merck Asthma Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 AstraZeneca
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Asthma Drugs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AstraZeneca Asthma Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Boehringer Ingelheim
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Asthma Drugs Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Boehringer Ingelheim Asthma Drugs Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    ...

7 Asthma Drugs Manufacturing Cost Analysis
    7.1 Asthma Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Asthma Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Asthma Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Asthma Drugs Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Asthma Drugs Market Forecast ( 2019-2025)
    11.1 EMEA Asthma Drugs Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Asthma Drugs Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Asthma Drugs Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Asthma Drugs Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Asthma Drugs Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Asthma Drugs Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Asthma Drugs Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Asthma Drugs Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Asthma Drugs Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Asthma Drugs Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer